Compounds > toluene
Page last updated: 2024-10-20

toluene and Basal Ganglia Diseases

toluene has been researched along with Basal Ganglia Diseases in 2 studies

methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruck, J1
Guss, H1
Jus, A1
Pineau, R1
Jus, K1
Villeneuve, A1
Gautier, J1
Pires, P1
Drolet, A1
Cote, M1
Villeneuve, R1

Trials

1 trial available for toluene and Basal Ganglia Diseases

ArticleYear
Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Current therapeutic research, clinical and experimental, 1974, Volume: 16, Issue:10

    Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Body Weight; Chlorpromazine; Chronic Disease; C

1974

Other Studies

1 other study available for toluene and Basal Ganglia Diseases

ArticleYear
[Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
    International pharmacopsychiatry, 1974, Volume: 9, Issue:3

    Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Delayed-Action Preparatio

1974